<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nonopioid analgesics commonly used for perioperative pain in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nonopioid analgesics commonly used for perioperative pain in adults</h1>
<div class="graphic"><div class="figure"><div class="ttl">Nonopioid analgesics commonly used for perioperative pain in adults</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="20%"></colgroup><colgroup width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Suggested dosing</td> <td class="subtitle1">Timing of administration</td> <td class="subtitle1">Comments</td> </tr> <tr> <td><strong>Acetaminophen (paracetamol)</strong></td> <td>Oral: 325 to 1000 mg every 4 to 6 hours; maximum dose 4 g per day <p class="extra_spacing_top">IV:</p> <ul class="decimal_heading"> <li>Weight ≥50 kg: 650 mg every 4 hours or 1000 mg every 6 hours, maximum dose 4 g per day</li> <li>Weight &lt;50 kg or with chronic alcoholism, malnutrition, or dehydration: 12.5 mg/kg every 4 hours or 15 mg/kg every 6 hours, maximum 750 mg/dose, maximum 3.75 g/day</li> </ul> </td> <td>Preoperative, intraoperative, and postoperative</td> <td> <ul> <li>Avoid regularly scheduled administration concomitantly with other medications that include acetaminophen (ie, combination drugs), to reduce risk of exceeding daily maximum dose</li> <li>No clinical advantage to IV form pre- and postoperatively in patients able to take oral form</li> <li>Avoid use in patients with alcoholic hepatitis, severe hepatic impairment, or severe active liver disease</li> <li>Oral acetaminophen at a reduced dose of 2 g per day is used safely in most patients with cirrhosis or advanced chronic liver disease</li> <li>Use acetaminophen cautiously in patients with mild to moderate hepatic impairment, (eg, limit to maximum 3g per day)</li> </ul> </td> </tr> <tr> <td colspan="4"><strong>Nonsteroidal anti-inflammatory drugs (NSAIDs)</strong></td> </tr> <tr> <td class="indent1">Celecoxib</td> <td>200 to 400 mg orally preoperatively; 200 mg orally every 12 to 24 hours postoperatively</td> <td rowspan="7">Preoperative*, intraoperative, and postoperative until hospital discharge</td> <td rowspan="7"> <ul> <li>Use with caution or avoid in patients with kidney dysfunction, cardiovascular disease, or peptic ulcer disease</li> <li>Use with caution in those at high bleeding risk, especially those taking concomitant anticoagulants</li> <li>All NSAIDs have US FDA boxed warning for risk of cardiovascular thrombotic events including MI and stroke; risk may be higher for COX-2-selective NSAIDs (eg, celecoxib)</li> <li>NSAIDs are contraindicated for patients having coronary artery bypass surgery</li> </ul> </td> </tr> <tr> <td class="indent1">Diclofenac</td> <td>50 mg orally every 6 to 12 hours, maximum 150 mg in 24 hours</td> </tr> <tr> <td class="indent1">Ibuprofen</td> <td>600 to 800 mg orally or IV every 6 to 8 hours</td> </tr> <tr> <td class="indent1">Ketoprofen</td> <td>50 to 75 mg orally every 6 to 8 hours</td> </tr> <tr> <td class="indent1">Naproxen (base)</td> <td>500 mg orally every 12 hours</td> </tr> <tr> <td class="indent1">Ketorolac<sup>¶</sup></td> <td> <p>Weight ≥50 kg and age &lt;65 years: 15 to 30 mg IV every 6 to 8 hours</p> Weight &lt;50 kg or age ≥65 years: 15 mg IV every 6 to 8 hours</td> </tr> <tr> <td class="indent1">Meloxicam<sup>Δ</sup></td> <td>15 mg orally (conventional tablet) or 30 mg IV once per day</td> </tr> <tr> <td colspan="4"><strong>Gabapentinoids</strong></td> </tr> <tr> <td class="indent1">Pregabalin</td> <td>75 to 150 mg orally once (preoperatively); 75 mg orally every 12 hours (postoperatively)</td> <td rowspan="2">Preoperative, postoperative until hospital discharge for patients with moderate to severe pain</td> <td rowspan="2"> <ul> <li>Synergistic respiratory depression when administered with opioids</li> <li>Evidence of perioperative benefit versus risk is uncertain, particularly for gabapentin</li> <li>Use reduced dose in kidney impairment</li> <li>Dose-dependent ataxia and somnolence; use reduced dose or avoid in older adults</li> </ul> </td> </tr> <tr> <td class="indent1">Gabapentin</td> <td>300 to 600 mg orally every 8 hours</td> </tr> <tr> <td><strong>Ketamine</strong></td> <td>Intraoperative: Bolus 0.25 to 0.5 mg/kg IV (maximum 35 mg) followed by an infusion of 0.1 to 0.5 mg/kg/hour (2 to 8 mcg/kg/minute)</td> <td>Intraoperative; postoperative should be considered if local policy allows</td> <td> <ul> <li>Reserve use for painful surgery in hospitalized patients</li> <li>Consider adding clonidine and low dose benzodiazepine as needed to mitigate adverse effects (eg, emergence reaction, hypertension)</li> <li>Reduce or discontinue 45 to 60 minutes before end of surgery to avoid prolonged emergence</li> <li>Reduce dose in patients with liver disease</li> </ul> </td> </tr> <tr> <td><strong>Lidocaine</strong></td> <td> <p>Bolus: 1 mg/kg IBW IV near time of induction</p> Infusion: 1 to 2 mg/kg IBW/hour intraoperatively</td> <td>Intraoperative; postoperative may be considered if local policy allows and surgery is associated with high degree of inflammation (ie, abdominal surgery, breast, or spine surgery)</td> <td> <ul> <li>Benefit likely limited to 24 hours postoperatively</li> <li>If titrating infusion outside of operating room patient should be in a monitored setting (eg, PACU or ICU)</li> <li>Not consistently shown to worsen cardiac conduction delays</li> <li>Reduce dose in patients with liver disease</li> <li>In underweight patients, use actual body weight to calculate dose</li> </ul> </td> </tr> <tr> <td><strong>Dexamethasone</strong></td> <td>4 to 8 mg IV or orally every 8 hours</td> <td>Preoperative, intraoperative, and postoperative</td> <td> <ul> <li>May improve analgesia and reduce PONV; dosing at higher end of range may be needed for analgesia</li> <li>May prolong duration of peripheral nerve blocks</li> <li>Causes transient hyperglycemia, not associated with increased surgical complications</li> </ul> </td> </tr> <tr> <td colspan="4"><strong>Alpha-2-receptor agonists</strong></td> </tr> <tr> <td class="indent1">Clonidine</td> <td> <p>IV: 1 to 4 mcg/kg once</p> <p>Oral: 200 to 300 mcg once</p> Transdermal patch: 0.2 mg/24 hours for patients receiving ketamine infusions for multiple days</td> <td>Preoperative and postoperative</td> <td> <ul> <li>Used to mitigate adverse effects of ketamine, particularly when ketamine is administered for two days or more or at high doses</li> </ul> </td> </tr> <tr> <td class="indent1">Dexmedetomidine</td> <td> <p>Loading dose, if hemodynamically stable (may be omitted): ≤0.5 mcg/kg IV over 10 to 15 minutes</p> Infusion: 0.3 to 0.7 mcg/kg/hour</td> <td>Intraoperative and postoperative</td> <td> <ul> <li>Used for patients who undergo very painful surgery and who also have risk factors for emergence delirium (eg, prior history, alcohol abuse)</li> <li>Loading doses greater than 0.5 mcg/kg associated with bradycardia and/or hypotension</li> <li>Postoperative administration should be in a monitored setting (eg PACU); monitoring should continue for one hour after infusion stopped</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">For further information on management of acute pain, refer to UpToDate content on nonopioid pharmacotherapy for acute pain.</div><div class="graphic_footnotes"><p>IBW: ideal body weight; IV: intravenous; US FDA: United States Food and Drug Administration; MI: myocardial infarction; COX-2: cyclooxygenase, isoform 2; PONV: postoperative nausea and vomiting; PACU: post anesthesia care unit; ICU: intensive care unit.</p>
<p>* For some surgical procedures, NSAIDs should not be administered until the surgeon confirms adequate intraoperative hemostasis.</p>
<p>¶ UpToDate contributors avoid ketorolac in patients with significant kidney impairment (ie, CrCl &lt;60 mL/minutes) and those at increased risk for acute kidney injury.</p>
Δ Due to its prolonged half-life (ie, ~24 hours) onset of full analgesic effect of meloxicam may be delayed relative to shorter-acting NSAIDs.</div><div id="graphicVersion">Graphic 139393 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
